NET

M.Pharm/M.S. Pharm , M.Sc. in Chemical Sciences. Hands on experience in formulation development, cell culture and HPLC/GC/LC- MS/GC-MS

Developing Repertoire of Orally Deliverable Phospholipid-Drug Conjugates for targeting Colorectal and Hepatocellular Carcinoma. MSc Biotechnology, Chemistry, Pharmacy, Pharmacology qualified with any National Level Test.

M.Sc. degree in the relevant area of Life Sciences with at least 55% or equivalent GPA. Candidates should have qualified in at least one National Level Examination

Candidates having research experiences in the area of renal diseases using Drosophila model, molecular biology, microscopy will be given preference. The initial appointment will be for one year and which may be extended depending upon the satisfactory performance of the candidate till the duration of the project.

MPharm or MSc; Doctorate degree in Life sciences, Biological Sciences/Biochemistry from a recognized University or equivalent

Ph.D. in Chemical Engineering, Biochemical Engineering, Environmental Engineering, Biochemistry, Biotechnology, Chemistry from a recognized University, Institute and having at least one research paper in Science Citation Indexed journal.

Boron based therapeutics against RNA viruses and associated post infection arthritis in chikungunya infection-a preclinical evaluation. First Class M.Sc. in Biochemistry, Microbiology, Biotechnology, life Sciences. OR 2nd class postgraduate with PhD. in Biochemistry, Microbiology, Biotechnology, life Sciences.

Noninvasive and in situ forming peptide-polymer hydrogel containing CPP decorated nanoparticles, photoresponsive agents with crystallin aggregates disaggregating propensity for potential cataract therapy.

M.Sc. in Life Sciences, Biotechnology, Biochemistry, Molecular Biology, Microbiology with minimum 60% marks or equivalent grade at both graduate and postgraduate level. Correlation and outcomes of established and novel serum, urine, tear film and imaging markers in Indian patients with moderate to severe Thyroid eye disease patients.